Table 1 Demographic characteristics and nutritional status of adolescents and young adults hospitalized for restrictive eating disorders by sex
From: Assessment of vitamin D among male adolescents and young adults hospitalized with eating disorders
Characteristic | Total (N = 565) | Sex | p a | |
|---|---|---|---|---|
Male (n = 93) | Female (n = 472) | |||
Age, years, mean (sd) | 15.49 ± 2.80 | 15.71 ± 2.67 | 15.44 ± 2.83 | 0.409 |
Race/ethnicity, n (%) | Â | Â | Â | 0.015 |
 Non-Hispanic white | 343 (60.71) | 46 (49.46) | 297 (62.92) |  |
 Hispanic | 94 (16.64) | 27 (29.03) | 67 (14.19) |  |
 Asian or NHOPIb | 44 (7.79) | 5 (5.38) | 39 (8.26) |  |
 Multiracial | 28 (4.96) | 5 (5.38) | 23 (4.87) |  |
 Other | 28 (4.96) | 3 (3.23) | 25 (5.30) |  |
 Unknown/Declined | 15 (2.65) | 2 (2.15) | 13 (2.75) |  |
 Non-Hispanic Black or African American | 13 (2.30) | 5 (5.38) | 8 (1.69) |  |
Diagnosis, n (%) | Â | Â | Â | 0.005 |
 Anorexia nervosa | 332 (58.76) | 40 (43.01) | 292 (61.86) |  |
 Unspecified feeding and eating disorder (UFED) | 55 (9.73) | 9 (9.68) | 46 (9.75) |  |
 Other | 44 (7.79) | 11 (11.83) | 33 (6.99) |  |
 Avoidant restrictive food intake disorder (ARFID) | 32 (5.66) | 12 (12.90) | 20 (4.24) |  |
 Other specified feeding and eating disorder (OSFED) | 92 (16.28) | 20 (21.51) | 72 (15.25) |  |
 Bulimia nervosa | 9 (1.59) | 1 (1.08) | 8 (1.69) |  |
 Binge-eating disorder | 1 (0.18) | 0 | 1 (0.21) |  |
BMI, kg/m2, mean (sd) | 17.55 ± 2.91 | 17.84 ± 3.77 | 17.49 ± 2.72 | 0.296 |
% median BMI, mean (sd) | 87.00 ± 14.00 | 87.03 ± 17.48 | 87.00 ± 13.23 | 0.987 |
25-hydroxyvitamin D (ng/mL), mean (sd) | 32.15 ± 11.87 | 30.06 ± 11.69 | 32.57 ± 11.87 | 0.063 |
25-hydroxyvitamin D categories, n (%) | Â | Â | Â | Â |
 Insufficiency (< 30 ng/mL) | 243 (43.01) | 41 (44.09) | 202 (42.80) | 0.818 |
 Deficiency (< 20 ng/mL) | 70 (12.39) | 17 (18.28) | 53 (11.23) | 0.059 |
 Severe deficiency (< 12 ng/mL) | 17 (3.01) | 8 (8.60) | 9 (1.91) | 0.001 |
Month (season) of Vitamin D lab, n (%) | Â | Â | Â | 0.346 |
 Summer (April through September) | 309 (54.69) | 55 (59.14) | 254 (53.81) |  |
 Winter (October through March) | 256 (45.31) | 38 (40.86) | 218 (46.19) |  |
Calcium, serum/plasma (mg/dL), mean (sd) | 9.42 ± 0.45 | 9.31 ± 0.62 | 9.45 ± 0.41 | 0.005 |
Phosphorous, serum/plasma (mg/dL), mean (sd) | 3.98 ± 1.90 | 3.99 ± 0.66 | 3.98 ± 2.06 | 0.987 |
Any Calcium, vitamin D, or multivitamin supplementation, n (%) | 89 (15.75) | 10 (10.75) | 79 (16.74) | 0.148 |
Calcium or vitamin D specific supplementation, n (%) | 46 (8.14) | 3 (3.23) | 43 (9.11) | 0.062 |
 Vitamin D supplementation | 29 (5.13) | 3 (3.23) | 26 (5.51) | 0.362 |
 Calcium supplementation | 31 (5.49) | 2 (2.15) | 29 (6.14) | 0.122 |
Multivitamin supplementation, n (%) | 64 (11.33) | 8 (8.60) | 56 (11.86) | 0.364 |